Altus Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,735
Closed -$288K 35
2025
Q1
$288K Buy
1,735
+5
+0.3% +$782 0.13% 35
2024
Q4
$250K Buy
1,730
+38
+2% +$5.89K 0.11% 37
2024
Q3
$274K Buy
1,692
+2
+0.1% +$319 0.13% 37
2024
Q2
$247K Buy
1,690
+138
+9% +$20.5K 0.12% 39
2024
Q1
$246K Sell
1,552
-741
-32% -$118K 0.13% 39
2023
Q4
$359K Buy
2,293
+419
+22% +$64.2K 0.21% 29
2023
Q3
$292K Buy
1,874
+37
+2% +$6.11K 0.2% 28
2023
Q2
$304K Buy
1,837
+30
+2% +$4.84K 0.24% 21
2023
Q1
$280K Buy
1,807
+42
+2% +$6.78K 0.23% 23
2022
Q4
$312K Buy
1,765
+94
+6% +$16.2K 0.27% 19
2022
Q3
$273K Buy
1,671
+9
+0.5% +$1.52K 0.23% 27
2022
Q2
$295K Buy
1,662
+8
+0.5% +$1.43K 0.23% 28
2022
Q1
$293K Buy
1,654
+8
+0.5% +$1.36K 0.2% 30
2021
Q4
$282K Buy
1,646
+9
+0.5% +$1.47K 0.17% 30
2021
Q3
$264K Buy
1,637
+8
+0.5% +$1.36K 0.17% 30
2021
Q2
$268K Sell
1,629
-106
-6% -$17.5K 0.17% 29
2021
Q1
$285K Buy
1,735
+9
+0.5% +$1.46K 0.2% 27
2020
Q4
$272K Buy
1,726
+298
+21% +$44K 0.21% 27
2020
Q3
$213K Buy
+1,428
New +$211K 0.2% 31
2020
Q1
Sell
-1,391
Closed -$203K 32
2019
Q4
$203K Buy
+1,391
New +$189K 0.2% 33

Other funds holding JNJ

Altus Wealth Management's JNJ Position: Q2 2025 in Review

Altus Wealth Management sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 1,735 shares — an estimated $288K sold.

Altus Wealth Management first reported a position in JNJ in Q4 2019 and held it in 20 quarters. The position peaked at $359K in Q4 2023. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Altus Wealth Management reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Altus Wealth Management sold 1,735 Johnson & Johnson shares in Q2 2025, an estimated $288K.
  • Altus Wealth Management first reported a position in Johnson & Johnson in Q4 2019 and held it in 20 quarters.
  • Altus Wealth Management's Johnson & Johnson position peaked at $359K in Q4 2023.
  • 4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Altus Wealth Management's 13F filing for Q2 2025, filed 17 Jul 2025.